Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).

Abstract

Authors

• Takeshi Sasaki
  Department of Next-Generation Pathology Information Networking, Faculty of Medicine, The University of Tokyo.
• Shin Ebara
• Tomoyuki Tatenuma
  Department of Urology, Kanagawa Cancer Center.
• Yoshinori Ikehata
  Department of Urology, University of Toyama, Toyama, Japan.
• Akinori Nakayama
  Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
• Makoto Kawase
  Department of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
• Masahiro Toide
  Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
• Tatsuaki Yoneda
  Department of Urology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
• Kazushige Sakaguchi
  Department of Urology, Toranomon Hospital, Tokyo, Japan.
• Jun Teishima
  Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
• Kazuhide Makiyama
  Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
• Hiroshi Kitamura
  Department of Urology, University of Toyama, Toyama, Japan.
• Kazutaka Saito
  Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
• Takuya Koie
  Department of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
• Fumitaka Koga
  Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan. f-koga@cick.jp.
• Shinji Urakami
  Department of Urology, Toranomon Hospital, Tokyo, Japan.
• Takahiro Inoue
  Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Keywords

External Resources